natgillin/translations-raw huggingface dataset:
ker je premalo zmogljivosti institucionalne oskrbe za ljudi z Alzheimerjevo boleznijo in jih bo v prihodnosti še manj; ker je zaposlenih v zdravstvu in socialnih delavcev, ki negujejo ljudi z Alzheimerjevo boleznijo premalo in se bo to pomanjkanje v prihodnosti še povečalo; ker je istočasno jasno, da je za takšne ljudi najbolje, da se jim pomaga, da ostanejo doma in v poznanem okolju,
whereas there is a shortfall in capacity in institutional care for people suffering from Alzheimer's disease, and that shortfall will worsen in the future; whereas there is a shortage of healthcare professionals and social workers caring for people suffering from Alzheimer's, and that shortage will increase in future; whereas at the same time it is clear that the best thing for such people is to assist them to remain in their familiar environment at home,
ker morajo Evropska unija in države članice pri oskrbi bolnikov in pomoči negovalcem stremeti k trojnemu cilju: zagotoviti kakovostno oskrbo bolnikov in čas počitka za negovalce, prilagojenega njihovim potrebam, ter omogočiti oskrbo bolnikov na domu ali v kakovostnih in inovativnih varstvenih ustanovah,
whereas, in connection with the care of dementia sufferers and support for carers, the European Union and the Member States must pursue a threefold objective: provide high-quality care for sufferers, ensure that carers can take advantage of periods of respite tailored to their needs, and ensure that sufferers can be looked after at home or in high-quality, innovative care facilities,
ker lahko moderne storitve telemedicine zagotovijo zelo učinkovito podporo bolnikom z Alzheimerjevo boleznijo in njihovim negovalcem ter lahko tako bolnikom pomagajo k boljši kakovosti življenja v znanem okolju in omogočijo dobro alternativo institucionalni oskrbi,
whereas modern telemedicine services can deliver very effective support for patients suffering from Alzheimer's, and for their carers, and can thus contribute to a better quality of life for patients in their familiar environment and provide a good alternative to institutional care,
ker je Alzheimerjeva bolezen stigmatizirana in odnos širše javnosti do te bolezni in ljudi, ki jih je prizadela, izolira bolnike in njihove sorodnike; ker je splošni pristop k tej težavi še zmeraj napačen in prizadete ter njihove sorodnike vodi v socialno izključenost; ker obstaja potreba po boljšem razumevanju stigmatizacije, predsodkov in diskriminacije, povezane z demenco in ker je treba preučiti vprašanje, kako preprečiti socialno izključenost in spodbuditi aktivno državljanstvo, da se v jedru vsake aktivnosti ohrani dostojanstvo in spoštovanje ljudi z demenco,
whereas there is a stigma attached to Alzheimer's disease and public attitudes towards the illness and the persons affected by it leave sufferers and their families and relatives isolated; whereas the overall approach to the problem is still the wrong one, leading those affected and their relatives to their social exclusion; whereas, therefore, there is a need for better understanding of the stigma, prejudice and discrimination associated with dementia whilst research is also needed on how to prevent social exclusion and encourage active citizenship so as to maintain the dignity and respect of the people with dementia at the core of any action,
ker je izboljšanje kakovosti za bolnike pogosto povezano s čustvenim življenjem bolnikovih sorodnikov,
whereas enhancing the quality of the patients is often linked to the emotional lives of the patients' relatives,
ker skupine za pomoč nudijo primerno okolje za skupinsko razmišljanje o podpori in delitvi „zavestne odgovornosti“ bolnikovih sorodnikov,
whereas Support Groups represent a suitable space for group thinking to support and share the ‘conscious responsibility’ of the patients' relatives,
ker Alzheimerjeve bolezni in drugih oblik demence ne smemo obravnavati kot normalne težave, s katero se posamezniki soočajo v procesu staranja, ne da bi bili pri tem upravičeni do primernega zdravljenja, zdravstvene pomoči in specializirane oskrbe,
whereas Alzheimer's and the other forms of dementia should not be perceived as a normal problem faced by individuals as part of the ageing process without them being entitled to suitable treatment, medical assistance and specialised care,
ker so možnosti za terapijo kljub znatno večji družbeni ozaveščenosti o Alzheimerjevi bolezni in njenemu večjemu znanstvenemu poznavanju, pri čemer je poudarek zlasti na značilnostih bolezni, in sicer ne samo pri klinični demenci, ampak tudi pri pojavu predhodnih stanj demence, še vedno omejene na simptomatska zdravila; ker med državami članicami, pa tudi znotraj njih, obstajajo občutne razlike in vrzeli v izobraževanju in usposabljanju osebja ter razpoložljivosti medicinske opreme za diagnosticiranje in raziskave; ker se Alzheimerjeva bolezen diagnosticira šele leta po pojavu bolezni, kar odloži kakršno koli možno zdravljenje za upočasnitev napredovanja bolezni,
whereas, although social awareness and scientific knowledge of Alzheimer's disease have increased substantially, underlining in particular how the disease is characterised not only by clinical dementia but also by the onset of pre-dementia earlier in time, therapeutic options are still limited to symptomatic drugs; whereas there are currently striking disparities between and even within Member States and shortcomings in terms of staff training and qualifications and the availability of equipment needed for diagnosis and research and whereas the diagnosis of Alzheimer's often takes place years after the onset of the disease, thus delaying any possible treatment to slow down the disease,
ker je najnovejši napredek pri uporabi zanesljivih bioloških označevalcev Alzheimerjeve bolezni spodbudil razvoj novih meril za opredelitev te bolezni kot klinične entitete, ki obsegajo ne samo fazo, v kateri je prizadet spomin in zaznavanje, temveč tudi predhodno fazo;
whereas recent advances in the use of reliable biomarkers for Alzheimer's disease have stimulated the development of new criteria defining Alzheimer's disease as a clinical entity encompassing not only a phase affecting memory and cognition, but also an earlier phase,
ker Alzheimerjeva bolezen in druge oblike demence ne prizadenejo le starejših ljudi, temveč lahko prizadenejo tudi mlade; ker je treba zato izboljšati dostop do diagnosticiranja, raziskave ter storitve oskrbe, pomoči in nastanitve mladih bolnikov,
whereas Alzheimer's disease and the other forms of dementia do not affect just the elderly, but may also be developed by young people; whereas access to diagnostic services, research and care, support and accommodation should be improved for young sufferers,
ker naj bi povečanje javne in poklicne ozaveščenosti o Alzheimerjevi bolezni, tako na nacionalni kot na evropski ravni, omogočilo ljudem, da prepoznajo prve znake bolezni, si prizadevajo za zgodnjo diagnostiko ter za dostop do zdravljenja in storitev v zgodnji fazi,
whereas raising greater public and professional awareness about Alzheimer's disease, both at national and European level, should empower the population to recognise the first signs of the disease, seek early diagnosis, and access treatment and services at an early stage,
ker bi večja osredotočenost na predhodno fazo Alzheimerjeve bolezni lahko prispevala k podpori razvoja ustreznih terapevtskih posegov, ki lahko upočasnijo napredek bolezni ter konec koncev odložijo razvoj najbolj hude oblike Alzheimerjeve bolezni,
whereas a greater focus on the pre-dementia phase of Alzheimer's disease could contribute to supporting the development of appropriate therapeutic interventions capable of slowing down the disease's progression, and ultimately delaying patients' entry into severe Alzheimer's, i.e. the most debilitating form of the disease,
ker razvoj učinkovitih povzročiteljev, ki spreminjajo bolezen (v nasprotju s čisto simptomatskimi povzročitelji) predstavljajo področje kritičnih in nujnih nezadovoljenih potreb bolnikov z Alzheimerjevo boleznijo,
whereas the development of effective disease-modifying agents (as opposed to purely symptomatic agents ) represents an area of critical and urgent unmet need for patients with Alzheimer's disease,
ker se poleg tega v diagnozi Alzheimerjeve bolezni, postavljene v skoraj 70 % primerov demence, ne upoštevajo različne vrste ugotovljenih možganskih poškodb in ker mladi in starejši bolniki nimajo enake patološke in klinične slike,
whereas, furthermore, the diagnosis of Alzheimer's disease delivered in almost 70 % of cases of dementia fails to take full account of the variety of cerebral lesions encountered in sufferers and of the fact that young and elderly sufferers do not show the same pathological and clinical picture,
poziva Svet, naj demenco razglasi za prednostno nalogo EU na področju zdravja, države članice pa odločno poziva, naj pripravijo posebne nacionalne načrte in strategije za Alzheimerjevo bolezen, da bi lahko začele reševati družbene in zdravstvene posledice demence ter zagotovile storitve in podporo ljudem z demenco in njihovim družinam, kot so to storile nekatere države članice, v katerih je načrt o Alzheimerjevi bolezni in podobnih boleznih, ki se je začel izvajati leta 2008, omogočil ureditev socialnozdravstvene oskrbe in temeljnih kliničnih raziskav te bolezni na nacionalni ravni;
Calls on the Council to declare dementia to be an EU health priority and strongly urges the Member States to develop specific national plans and strategies for Alzheimer's disease in order to deal with the social and health consequences of dementia and to provide services and support for people with dementia and their families, as has been done in several Member States where the ‘Alzheimer's and similar diseases’ plan launched in 2008 has made it possible to coordinate medical and social care and clinical and basic research into these diseases at national level;
pozdravlja pobudo držav članic o skupnem načrtovanju na ravni EU, da se spodbudi raziskave na področju Alzheimerjeve bolezni in drugih nevrodegenerativnih bolezni ter spodbuja Komisijo, naj nadaljuje z uvajanjem dejavnosti za reševanje izzivov, povezanih z zdravjem, družbo, tehnologijo in okoljem, ki se pojavijo pri zdravljenju Alzheimerjeve in drugih nevrodegenerativnih bolezni.
Welcomes the EU Joint Programming initiative promoted by the Member States in order to boost research on Alzheimer's and other neurodegenerative diseases and encourages the Commission to continue launching activities to tackle health-related, social, technological, and environmental challenges for the treatment of Alzheimer's and other neurodegenerative diseases;
poziva Svet in Komisijo, naj koncept demence upoštevata pri pripravi prihodnjih ukrepov na področju politike preventivnega zdravstva, zlasti v povezavi z boleznimi srca in ožilja, duševnim zdravjem, fizično aktivnostjo, izobraževanjem na področju zdravstva in novimi tehnologijami;
Calls on the Council and the Commission to take account of the concept of dementia when preparing future actions in the area of preventive health policy, notably in relation to its interaction with cardiovascular illnesses, mental health, physical activity, education in the field of health and new technologies;
poziva države članice, naj državljanom EU zagotovijo informacije o življenjskem slogu, da se upočasni ali prepreči nastop Alzheimerjeve bolezni in drugih oblik demence in da se spodbudi koncept zdravega življenjskega sloga za zdrav um;
Calls on the Member States to provide EU citizens with lifestyle information with a view to delaying or preventing the onset of Alzheimer's and other forms of dementia, by promoting the concept of ‘a healthy lifestyle for a healthy brain’;
predlaga, naj Svet in Komisija razmislita o razglasitvi evropskega leta duševnega zdravja, ki bo dopolnjeval svetovni dan boja proti Alzheimerjevi bolezni 21. septembra, da se poveča ozaveščenost glede bolezni možganov, povezanih s staranjem, in glede načinov zaznavanja in ugotavljanja zgodnjih simptomov takšnih bolezni, in sicer s kampanjami obveščanja javnosti o njihovem preprečevanju in o zdravljenju možganske kapi; evropsko leto bi tudi omogočilo spodbujanje izmenjave izkušenj v evropskih državah;
Suggests that the Council and the Commission consider launching a European Year of Mental Health, complementing World Alzheimer's Day on 21 September,in order to raise awareness of brain-related diseases associated with ageing and of ways to detect and identify early symptoms of such diseases, with public information campaigns on their prevention as well as about the treatment of cerebral vascular accidents; The European year should be also a place to promote the exchange of good practices in European countries;
poudarja, da bo (a) vedno večji delež starejšega prebivalstva in (b) iz tega naslova čedalje večja obremenjenost javnih financ in zasebne storilnosti zaradi povečanih stroškov za starejše prebivalstvo državam članicam povzročil strukturno težavo; Evropska unija bi zato morala v svoji dolgoročni strategiji sprejeti usmeritev odločnega spodbujanja načel preprečevanja (v smislu zdravstvenih praks ter v smislu spodbujanja bolj zdravega načina življenja).
Points out that (a) the increasingly ageing population and b) the mounting pressure on public finances and private productivity due to increased expenses for this ageing population will create a structural problem for the Member States; the European Union should therefore adopt in its long-term strategy the policy of firm promotion of the principle of prevention (in terms of medical practices as well as in terms of encouraging healthier lifestyles).
poziva Svet in Evropsko komisijo, naj priznata vlogo združenj bolnikov na področju nevrodegenerativnih bolezni in jih vključita v informativne in preventivne kampanje ter kampanje za podporo dementnim osebam, pa tudi v pripravo raziskovalnih programov;
Calls on the Council and the Commission to recognise the role of patients' associations in the area of neurodegenerative diseases and to involve them in information and prevention campaigns and support measures for dementia sufferers and in the preparation of research programmes;
predlaga, naj Komisija razmisli o spodbujanju dneva negovalcev, s katerim bi povečali ozaveščenost in priznali ključno vlogo formalnih in neformalnih negovalcev v Evropi;
Suggests that the Commission consider promoting a ‘Carers Day’ to raise awareness of and recognise the crucial role of formal and informal carers across Europe;
poudarja, da mora odkrivanje učinkovitih posegov, ki preprečujejo pojav Alzheimerjeve bolezni ali zadržijo njeno napredovanje, postati nujno v vsakem pogledu;
Stresses that discovering effective interventions that prevent the onset of or delay Alzheimer's progression must take on an all encompassing urgency;
poziva Svet in Komisijo, naj zagotovita ozaveščanje javnosti v Uniji o demenci, kar bi pripomoglo k prepoznavanju zgodnjih simptomov demence ter omogočilo zgodnje diagnosticiranje ter ustrezno zdravljenje in primerno podporo;
Calls on the Council and the Commission to act to raise public awareness in the Union concerning dementia, facilitating recognition of the early symptoms of dementia with a view to early diagnosis and the corresponding treatment and appropriate support;
poudarja, prednostni pomen preprečevanja ter pomembnost zgodnjega diagnosticiranja za učinkovite posege; poudarja potrebo in poziva države članice naj izboljšajo epidemiološke in klinične podatke, da bi pomagale usmeriti raziskave, rehabilitacijo in ukrepe, zlasti v asimptomatskih fazah in pred nastopom nezmožnosti;
Underlines the primality of prevention as well as the relevance of early diagnosis for effective interventions; underlines the need and calls on the Member States to improve epidemiological and clinical data to help direct research, rehabilitation and action, in particular during the asymptomatic phases and before the onset of incapacity;
poudarja, da trenutno ni nobene posebne politike preprečevanja Alzheimerjeve bolezni, in zato spodbuja k njenemu oblikovanju, tudi na evropski ravni; temeljila naj bi na zagotavljanju okolja, ki bi spodbujalo telesne in umske aktivnosti bolnikov, prehrani, ki bi bila skladna s priporočili platforme EU za ukrepanje glede prehrane, telesne aktivnosti in zdravja, ter na spodbujanju vseh politik za zmanjševanje aktivnega in pasivnega kajenja;
Notes that at present there is no specific policy on the prevention of Alzheimer's disease, and calls, therefore, for the establishment of such a policy, including at European level, to be based on the need to maintain an environment conducive to patients' physical and intellectual activity and a diet consistent with that recommended by the European Platform for Action on Diet, Physical Activity and Health and on the promotion of all policies to reduce smoking, both active and passive;
je prepričan, da so testi za zgodnje diagnosticiranje, ki jih je predlagala mednarodna delovna skupina za nova merila za Alzheimerjevo bolezen, raziskave dejavnikov tveganja in opredelitev meril za zgodnje diagnosticiranje bistvenega pomena;
Is convinced that the early diagnosis tests recently proposed by the International Working Group on the New Criteria for Alzheimer's Disease, research into risk factors and the definition of early-diagnosis criteria are vitally important;
spodbuja vse države članice, naj se aktivno vključijo v opredelitev, oblikovanje in izvajanje skupnih protokolov za zgodnje diagnosticiranje, vzpostavijo biološke označevalce, da bi gradili na novih vrstah terapij za demence in predhodna stanja demence, ter oblikujejo skupni raziskovalni načrt na področju nevrodegenerativnih bolezni in izmenjavo izkušenj na področju raziskav teh bolezni ter tako zmanjšajo neenakosti med državami članicami in znotraj njih na področju diagnosticiranja in zdravljenja; poudarja, da bodo standardni operacijski postopki za ocenjevanje označevalcev bolezni bistveni za odkrivanje zdravila in razvoj učinkovitejše, tehnološko podprte nege bolnikov z Alzheimerjevo boleznijo;
Encourages all the Member States to engage actively in the definition, development and implementation of common protocols for early diagnosis, to establish biomarkers with a view to building on the emergence of new therapies for both dementia and pre-dementia, and to define a common research agenda in the field of neurodegenerative diseases and the sharing of best practices in the area of research into neurodegenerative diseases, thus reducing the prevailing inequalities between Member States and within Member States as regards diagnosis and treatment; points out that standard operational procedures for the assessment of disease markers will be key to drug discovery and to the development of more effective, technology-assisted care of patients with Alzheimer's disease;
spodbuja države članice, naj zagotovijo, da bodo zdravila, ki zavirajo nastop Alzheimerjeve bolezni, na voljo vsem obolelim za to boleznijo in ne samo tistim, pri katerih je bila ugotovljena huda oblika;
Encourages Member States to ensure that drugs able to slow the onset of Alzheimer's are made available to all patients suffering from the disease and not only patients who are diagnosed with severe cases of Alzheimer's;
spodbuja Evropsko komisijo, naj pripravi smernice za oblikovanje in izvajanje skupnega sistema zgodnjega diagnosticiranja, ki bo temeljil na večdisciplinarnem preverjanju spominskih sposobnosti, ter ustreznega sistema obveščanja in informiranja, ki bo bolnikom in njihovim družinam omogočil, da se bodo z boleznijo kakovostno spoprijeli;
Encourages the Commission to draw up guidelines for the development and implementation of common early diagnostic services based on a multidisciplinary assessment of the patient's state of memory and an adapted notification and information system to provide patients and their families with the best possible framework in which to approach the onset of the disease;
spodbuja države članice k ustanavljanju specializiranih centrov in zagotavljanju zadovoljive zdravstvene opreme (zlasti naprav za slikanje z magnetno resonanco, ki neizpodbitno prispevajo k raziskavam demence) na njihovem celotnem ozemlju;
Encourages the Member States to establish specialist centres and to provide satisfactory medical equipment (including magnetic resonance imaging, whose contribution to dementia research is indisputable) nationwide;
poziva Svet in Komisijo, naj pri snovanju akcijskih načrtov za raziskave upoštevata hitro širjenje demence in Alzheimerjeve bolezni ter njun vpliv;
Calls on the Council and the Commission to take account of the rapid spread of dementia and Alzheimer's, and their impact, when drawing-up action plans for research;
poziva države članice, naj razvijejo politike za lažji dostop do financiranja raziskav na področju demence in Alzheimerjeve bolezni, vključno z raziskavami preprečevanja, in sicer sorazmerno z ekonomskim vplivom teh bolezni v družbi;
Urges the Member States to develop policies for facilitating access to research funding in the field of dementia and Alzheimer's, including research into prevention, on a basis proportionate to these illnesses' economic impact on society;
poudarja pomen večdisciplinarnega pristopa v zvezi z načini, na katere je mogoče s sodelovanjem in usklajevanjem na področju raziskav na evropski ravni izboljšati znanje, diagnosticiranje, zdravljenje, preprečevanje in socialne raziskave počutja bolnikov ter njihovih družin in negovalcev; meni, da raziskovanje na področju potrjevanja novih meril za diagnosticiranje, razvoj zgodnjih presejalnih testov in opredeljevanje dejavnikov tveganja za napredovanje bolezni iz stanja pred demenco na napredne faze bistvenega pomena; predlaga vključitev predstavnikov bolnikov, zdravstvenih organizacij in izvajalcev zdravstvenih storitev v ta postopek; zato ocenjuje, da ima izvajanje obsežnih epidemioloških in kliničnih raziskav z mednarodnim sodelovanjem neizpodbitno dodano vrednost;
Points to the importance of a multidisciplinary approach to ways in which cooperation and coordination in the field of research at European level can improve knowledge, diagnosis, treatment, prevention, and social research into the welfare of patients and their families and carers; believes that research on the validation of new diagnostic criteria, the development of early screening tests, and the identification of risk factors for the progress of the disease from the pre-dementia phase to the advanced stages is crucial; recommends that representatives of patients, healthcare organisations and medical-service providers be involved in this process; sees, this being the case, clear added value in conducting large-scale epidemiological and clinical studies on the basis of transnational collaboration;
priznava pomen podpore Evropske unije 34 projektom o nevrodegenerativnih boleznih v višini 159 milijonov EUR; meni pa, da je v okviru prihodnjega 8. okvirnega programa za raziskave in razvoj nujno odpraviti razdrobljenost raziskav, zlasti o Alzheimerjevi bolezni, in vključiti projekte na nezadostno raziskanih področjih zdravljenja brez zdravil ter vedenjskega in kognitivnega zdravljenja;
Recognises the current importance of the European Union's support, totalling EUR 159 million, for 34 projects on neurodegenerative diseases; considers it essential, nevertheless, in the context of the forthcoming 8th RDFP, to address the fragmented nature of research, particularly that on Alzheimer's, and to include projects in the insufficiently explored fields of non-drug, behavioural and cognitive therapies;